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Abstract 
Hope (goal-directed thinking) and patient activation (knowledge and skills to manage one’s 
illness) are both important in managing chronic conditions like schizophrenia.  The relationship 
between hope and patient activation has not been clearly defined.  However, hope may be 
viewed as a foundational, motivating factor that can lead to greater involvement in care and 
feelings of efficacy.  The purpose of the present study was to understand the prospective 
relationship between hope and patient activation in a sample of adults with schizophrenia (N = 
118).  This study was a secondary data analysis from a study on Illness Management and 
Recovery (IMR) – a curriculum-based approach to schizophrenia self-management.  Data were 
collected at baseline (prior to any intervention), and at 9 and 18-month follow-up.  As predicted, 
hope and patient activation were significantly related with each other, showing large positive 
concurrent correlations.  Demographics and background characteristics were not significantly 
related to patient activation or hope.  Longitudinal analyses found no specific directional effect, 
yet suggested that hope and patient activation mutually influence each other over time.  Our 
findings add flexibility in designing recovery-based interventions -- fostering hope may not be a 
pre-requisite for activating consumers to be more involved in their own care.  
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1. Introduction 
Schizophrenia is often a chronic and debilitating mental illness, and can be associated 
with feelings of hopelessness (Lysaker et al., 2008).  Yet, current mental health policies in the 
U.S. support a recovery-oriented system where consumers are not passive recipients of care but 
are encouraged to partner with mental health providers and actively engage in treatment 
(President’s New Freedom Commission on Mental Health, 2003).  Hope is considered a critical 
factor that may motivate people with schizophrenia to become engaged in treatment.  Although 
correlational research suggests a relationship between hope and patient activation, little is known 
about the relationship between hope and activation over time and whether one may be necessary 
for the other to grow.  Establishing the stability and predictability between these two variables 
over time is critical for developing effective interventions.  The purpose of this study was to 
assess possible connections between hope and patient activation over time with a long-term goal 
of improving outcomes in individuals with schizophrenia. 
1.1. Hope 
Hope is frequently defined as a set of goal-focused cognitions consisting of pathways and 
agency thinking (Snyder, 1994; Snyder et. al, 1998).  Pathways thinking refers to goal-focused 
planning and generating strategies for reaching goals.  Agency thinking involves motivating 
oneself to use these strategies to achieve one’s goals.  The interaction between the two is 
necessary for successful pursuit of one’s goals.  According to Snyder et al. (1998), a person high 
in hope tends to generate more strategies for pursuing goals and is more likely to use the 
strategies, making goal attainment more probable.  
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Consumers of mental health services refer to hope not only as an important foundation 
for recovery from severe mental illness, but, as a ‘turning point’ for recovery (Kirkpatrick et al., 
2001) and even “a matter of life and death” (Deegan, 1996).  Mental health professionals can 
play an important role in fostering hope and maintaining supportive relationships with 
consumers.  For example, interviews of consumers with schizophrenia found that setting and 
achieving goals, either long or short term, facilitated hope; other strategies included maintaining 
relationships, having control over one’s illness, and spiritual beliefs  (Kirkpatrick et. al. 2001).  
Similar conclusions of setting and pursuing goals and increasing motivation were identified in 
interviews with consumers with psychotic illnesses, their significant others, and mental health 
nurses (McCann, 2002).  Alternatively, hopelessness has been linked with being less likely to 
take action (Lysaker et al., 2008; Hoffman et al., 2000).  Together, these findings are consistent 
with Deegan’s (1988) earlier contention that regaining hope is critical for treatment engagement.  
1.2. Patient activation  
Patient activation is defined as the knowledge, skills, and confidence necessary to 
manage one’s illness (Hibbard et al., 2004).  All of these factors play a key role in managing 
chronic health conditions.  In developing a measure of patient activation, Hibbard et al. (2004) 
emphasized patients’ beliefs about their active involvement in care as a crucial first step to self-
management. With knowledge and confidence, patients can play an active role in managing their 
conditions in collaboration with healthcare providers, and gain valuable skills and behaviors to 
not only maintain that functioning but also prevent any health declines.  The Patient Activation 
Measure has been widely used, and has been translated into a number of different languages 
(Alegria et al., 2009; Maindal et. al., 2009; Rademakers et. al., 2012).  Moreover, patient 
activation is associated with a variety of health behaviors and outcomes. 
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In a study of consumers with chronic conditions, including diabetes, asthma, heart failure, 
coronary artery disease, and chronic pain, Mosen et al. (2006) found that higher patient 
activation was associated with better medication adherence, more involvement in self-
management services, and better quality of life and physical and mental functioning.  Hibbard et 
al. (2007) studied similar populations and found that the amount of self-management behaviors 
increased in consumers with high activation, and the change in behaviors lasted over time.  
Similar findings have been reported for patient activation in mental health settings.  Green et al. 
(2010) found high activation was related to better medication adherence, better physical and 
mental health, higher recovery rates, and fewer symptoms.  Positive aspects of patient activation 
were also supported by another study of mental health consumers conducted by Salyers at al. 
(2009), who found high patient activation related to better self-management and recovery 
outcomes. 
1.3. Hope and patient activation 
While hope and patient activation may constitute important factors in treatment outcomes 
for people with chronic illnesses, few studies have examined the relationship between these 
constructs.  Skolasky et al. (2009) measured patient activation and psychological variables, 
including hope, optimism, self-efficacy, and locus of control in 283 people prior to surgery.  
Although the focus of that study was on the psychometric properties of a specific measure of 
activation, they found strong positive correlations between patient activation and psychological 
factors, including hope.  Similarly, Green et al. (2010), who tested psychometric properties of the 
Patient Activation Measure, found a strong positive correlation between patient activation and 
hope, as a subscale of Recovery Assessment Scale (Corrigan et al, 2004).  Focusing on a sample 
of people with schizophrenia, Kukla et al. (2013) found that greater hope and recovery attitudes 
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were associated with greater involvement in managing one’s illness.  However, only cross-
sectional analyses were conducted, and longitudinal analyses are useful to better understand the 
predictive relationship between the two constructs.  Furthermore, understanding the longitudinal 
process would potentially inform interventions.  For example, if hope is truly foundational and 
found to be a precursor to patient activation, this would suggest that hope inducing interventions 
would need to come prior to other activating interventions.  Yet, studies have shown hope to be 
difficult to instill (Weis and Speridakos, 2011).  A finding suggesting that hope is not a precursor 
to patient activation might support alternative approaches, focusing more on enhancing 
knowledge and skills directly related to illness management.  Thus, a better understanding of the 
likely direction between hope and patient activation could help clarify where and when to best 
intervene. 
Using data from the Kukla et al. (2013) study, the purpose of the current study was to 
examine the prospective relationship between hope and patient activation over time.  Given the 
primacy of hope in the aforementioned literature, we hypothesized that hope would be a stronger 
predictor of subsequent patient activation than the reverse.  To the authors’ knowledge, this is the 
first study to investigate the relationship between hope and patient activation longitudinally in 
consumers with schizophrenia.    
2. Methods 
2.1. Setting and Participants 
The present study used data previously collected from a study on Illness Management 
and Recovery (IMR), a structured program that helps consumers effectively deal with severe 
mental illness by raising awareness about the illness and teaching them new ways to cope with 
their illness (Mueser and Gingerich, 2005).  Data were collected at baseline (prior to any 
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intervention), at 9 and 18 months later, through interviews with a trained project manager and/or 
research assistant.  Participants were at least 18 years old, currently receiving mental health 
services at a VA Medical Center or a community mental health center in [City], and diagnosed 
with schizophrenia spectrum disorders (schizophrenia or schizoaffective disorder) according to 
the Structured Clinical Interview for DSM-IV (SCID; First et al., 1996).  Participants with any 
condition that would inhibit taking part in a study for a period of 18 months were excluded.  
These included physical health or cognitive dysfunction as measured by a cognitive screener 
(Callahan et al., 2002).  The Institutional Review Boards at the [VA and University] approved 
the study. 
The parent study recruited 118 participants and randomly assigned them to one of two 
treatment conditions: IMR (N=60) or problem-solving (N=58).  In the original study, there were 
no experimental differences on outcomes over time; details on the study conditions are described 
in more detail elsewhere (Salyers et al., 2014).  Services were delivered to participants at either 
the VA (N = 52, 44.1%) or the community mental health center (N = 66, 55.9%).  The mean age 
was 47.6 years (SD = 8.9).  Most participants were male (N = 94, 79.7%).  Seventy two (61.0%) 
were African American, 40 (33.9%) were Caucasian, and 6 (5.1%) were of other race.  
Educational level varied from less than high school (N = 40, 33.9%), to high school diploma (N 
= 39, 33.1%), and some college or college degree (N = 37, 31.3%).  At 9 months, 84 participants 
(71%) were located and interviewed at follow-up.  Dropouts did not significantly differ from the 
9-month sample on any demographic except for age.  Dropouts were younger (M = 45.0, SD = 
9.9) than non-dropouts (M = 48.7, SD = 8.2), t(116) = -2.11; p = .037. 
2.2. Measures 
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 Patient activation was assessed with the Patient Activation Measure for mental health 
(PAM-MH; Hibbard et al., 2005).  This 13-item scale that specifically focuses on mental health 
(e.g., “I am confident that I can take actions that will help prevent or minimize some symptoms 
or problems associated with my mental health condition”).  Scores range from 0 (least activated) 
to 100 (high activated).  The PAM-MH has shown strong test-retest reliability, reliability in 
Rasch analyses, and correlation with similar concepts (Green et al., 2010).  The scale has been 
successfully used in other samples with schizophrenia (Druss et al., 2010; Green et al., 2010; 
Salyers et al., 2009).  Cronbach’s alpha was .88 for the present study.  
 Hope was assessed with the State Hope Scale (Snyder et al., 1996), a six-item measure 
asking consumers to indicate the extent of their agreement with statements related to pathways 
thinking (e.g., “I can think of many ways to reach my current goals”) and agency thinking (e.g., 
“At the present time, I am energetically pursuing my goals”) on an 4-point scale ranging from 
“Definitely False” to “Definitely True.” Internal consistency, convergent and discriminant 
validity, and sensitivity have been established (Snyder et al., 1996).  Although psychometric 
properties were established in a college-student sample, the scale has been successfully used in 
individuals with schizophrenia, major depression, and bipolar disorder (Dickerson, 2002; 
McGrew et al., 2004).  The state version of the hope scale was selected for the parent study 
because it was hypothesized that hope among consumers with schizophrenia could change across 
time, particularly in response to the IMR intervention.  In this sample, Cronbach’s alpha was .82. 
2.3. Data Analyses 
 Preliminary analysis involved examination of the distribution of scores on hope, patient 
activation, and demographics.  We created a correlation matrix to examine bivariate relationships 
among baseline demographics (i.e., gender, age, race, educational level), and hope and patient 
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activation, (baseline, 9 months, and 18 months).  We examined the relationship between hope 
and patient activation over time through a sequence of cross-lagged panel models (Bollen, 1989; 
Little et al., 2007; Wu et al., 2013).  All outcome variables were standardized so the path 
coefficients can be interpreted as standardized regression coefficients.  First, we freely estimated 
all hypothesized path coefficients (the base model).  Second, we imposed some constraints to test 
whether the assumption of stationarity held for the data.  More specifically, we constrained to 
equality the structural path coefficients linking adjacent measurements of the same variable (i.e., 
the coefficients linking baseline to 9 mo. and 9 mo. to 18 mo. measurement of hope; likewise for 
patient activation).  In addition, we constrained the within-occasion residual correlation between 
hope and patient activation to be equal across time (9 mo., and 18 mo.).  The model with these 
constraints is labeled model 1.  We used a likelihood ratio test (i.e., chi-square difference test) to 
test if model 1 provided worse fit to the data than the base model.  If the likelihood ratio test is 
not significant, then the constraints in model 1 are plausible.  Note that this test is an omnibus 
test which controls familywise Type I error (Little, 2013). 
Third, we introduced five time-invariant covariates (i.e., randomized condition, baseline 
age, gender [male = 1], race [white = 1], education [beyond high school = 1]) to control for 
potential confounding factors.  Note that the number of treatment sessions attended was 
unrelated to outcomes in the parent study and was not included in this model. The covariates, 
allowed to be correlated with the baseline measures, were used to predict the outcomes at 9 and 
18 months.  Finally, two path coefficients (i.e., the effect of hope on patient activation; the effect 
of patient activation on hope) were constrained to be equal to examine whether the two effects 
had the same magnitude of strength.  Again, a likelihood ratio test was performed to test if the 
constraint was tenable.  
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Each model was evaluated using the multi-index approach (Hu and Bentler, 1999), based 
on the Comparative Fit Index (CFI; values >.90 are acceptable but values > .95 are preferred), 
Tucker-Lewis Index (TLI; values >.90 are acceptable but values > .95  are preferred), Root Mean 
Square Error of Approximation (RMSEA; values <.08 are acceptable, but <.05 are preferred), 
and Standardized Root Mean Square Residual (SRMR; values <.08 are acceptable but values 
<.06  are preferred).  Mplus version 7.11 (Muthén and Muthén, 1998-2013) with full information 
maximum likelihood estimation was used for the analyses. 
3. Results 
Overall patient activation reported by participants was moderate, with a mean = 54.7 (SD 
= 16.1).  Participants’ level of hope was above the scale’s theoretical mean of 2.5 (M = 2.9, SD 
= .66).  As predicted, hope and patient activation were significantly related with each other (see 
Table 1), showing a large positive concurrent correlations at baseline (r = .57, p < 0.001), 9 
months (r = .62, p < 0.001), and 18 months (r = .67, p < 0.001).  Demographics and background 
characteristics, including gender, race, education, age were not significantly related to hope or 
patient activation.   
The final cross-lagged panel model is model 1, shown in Fig. 1.  The base model showed 
acceptable fit [χ2(4, n=118)=3.059, p=.55, RMSEA= 0.0 (90%CL=0 - 0.123), CFI=1.00, TLI=1.00, 
SRMR=0.022].  The likelihood ratio test indicated that the constraints on the corresponding path 
coefficients and residual correlations (model 1) were tenable [χ2(dif=5)=1.165, p=.95], and the 
confidence interval for RMSEA became appreciably narrower.  Model 1 provided adequate fit to 
the data [χ2(9, n=118)=4.224, p=.90, RMSEA=0.0 (90%CL=0 - 0.046), CFI=1.00, TLI=1.00, 
SRMR=0.032] (the final model).  On the other hand, inclusion of time-invariant covariates did 
not improve the model fit [χ2(dif=30)=30.29, p=.45], and none of the covariate effects was 
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significant.  Thus, these covariates were removed.  Lastly, the equality constraint on the two 
effects (i.e., β3=β4 in Fig. 1) was tenable [χ2(dif=1)=0.239, p=.62] indicating that the magnitudes of 
the two effects were not statistically different.  
4. Discussion 
This is the first study to examine hope and patient activation longitudinally, and to 
attempt to sort out potential directionality in these relationships over time.  Given the theoretical 
relevance of both constructs to recovery, combined with the lack of empirical data in people with 
schizophrenia-spectrum disorders, this study contributes important new knowledge to the field. 
We found a large positive correlation between hope and patient activation at each time period.  
Our cross-lagged panel models revealed that consumers with greater hope tended to become 
more activated in their treatment over time.  In addition, activation was also associated with 
improved hope over time.  Contrary to our expectation, hope was not a stronger predictor of 
changes in patient activation over time.  That is, hope and patient activation were not just 
concurrently related (Kukla et al, 2013), but both constructs predicted the future status of 
consumers, and the influence was reciprocal and consistent over time. 
Our correlational findings are similar to Green (2010), who found positive relationships 
between hope and patient activation in another sample of people with mental illness, and to 
Skolasky et al. (2009) who found positive relationships between hope and patient activation in 
another health condition (i.e., chronic back pain).  That hope and patient activation are 
empirically related is consistent with studies emphasizing hope as an important factor for 
consumers’ active engagement in recovery (Kirkpatrick et al., 2001; McCann, 2002).  Similarly, 
prior research (Hoffman et al., 2000; Lysaker et al., 2008) has shown that individuals with low 
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hope tend to give up easier and are less involved in their recovery.  It is plausible that hope can 
lead to increased activation and involvement in recovery.   
Yet our model shows that it is similarly plausible that patient activation leads to increased 
hope.  Hence, it suggests both pathways impact one another and they will likely influence each 
other going forward.  One of the clinical implications of our findings is that when designing 
interventions to foster recovery from mental illness, starting with either (or both) hope or patient 
activation may be equally desirable for improvements in the other across time.   This gives 
treatment providers greater flexibility in how to design and implement interventions, depending 
on what is most practical at the time. 
One may emphasize hope in interventions, as hope has been related to therapy outcomes.  
For example, Irving et al.’s (2004) research shows that pathways and agency present at the 
beginning of the psychotherapy lead to more positive outcomes of therapy sessions.  However, 
Schrank et al. (2011) looked closely at interventions designed to increase hope in mental health 
consumers and found that studies with hope as a primary outcome were almost missing.  In their 
systematic review, they reported one pilot study that was a hope-instilling group therapy session 
in mental health consumers (Cheavens et al., 2005).  Although their intervention did not yield 
overall significant change in hope, the agency component did improve.  Another study conducted 
by Tollet and Thomas (1995) was a nursing intervention to increase hope, self-efficacy, and self-
esteem, and decrease depression in homeless veterans.  Hope was the only measure showing 
statistically significant improvement.  
Conversely, one may emphasize patient activation given links to greater self-management 
of mental illness in people with medical conditions (Mosen et al., 2006; Hibbard et al., 2007) as 
well as mental health conditions (Salyers et al., 2009; Green et al., 2010; Kukla et al., 2013). For 
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example, Alexander et al. (2012) noted that as little as establishing patient-physician 
relationships might help foster patient activation.  Alegria and colleagues (2008) found increases 
in patient activation following three sessions coaching consumers to ask questions in treatment, 
and Druss et al. (2010) found increases in patient activation following a peer support intervention 
for managing comorbid medical conditions in schizophrenia. Given the difficulty in targeting 
hope specific-interventions (Weis and Speridakos, 2011), combined with our findings that hope 
is not necessarily a precursor, patient activation interventions may be a more promising avenue. 
Our study is limited in the ability to make causal conclusions.  Our cross-lagged panel 
models suggest a plausible model whereby hope and patient activation mutually influence each 
other over time.  However, further research is needed to look more closely at this relationship, 
and experimental designs could be used to better understand the relationship between the two 
variables.  For example, an intervention specifically designed to instill hope could be 
experimentally manipulated to examine the impact on patient activation and recovery outcomes.  
Furthermore, our sample included primarily male participants, all of whom had enrolled in a 
study to improve illness self-management.  This can limit the generalizability of our findings.   
Despite these limitations, this study provides new information that hope and patient 
activation may be related to each other for consumers with schizophrenia, and the relationships 
may remain constant over time.  The recovery process is highly individualized, and our findings 
support different potential pathways to recovery.  Interventions involving multifaceted 
approaches (including hope-instilling and patient-activation enhancement strategies) may be 
more effective at impacting the different driving-forces toward recovery. The study also suggests 
that evaluating mutually influencing outcome variables may be better suited for facilitating our 
understanding of the interactive processes and mechanisms of recovery pathways.       
Running head: PATIENT ACTIVATION AND HOPE IN SCHIZOPHRENIA 
14 
 
 
Author Contributions 
Authors Oles and Salyers were involved in the study design.  Salyers designed and directed the 
parent study from which the data were obtained.  Authors Fukui and Rand were involved in data 
analysis and writing up the results.  Oles wrote the first draft of the manuscript.  All authors 
contributed, edited, and approved the manuscript and subsequent revisions. 
 
Conflict of interest 
None of the authors have any conflicts of interests to declare. 
 
Acknowledgement 
The research reported here was supported in part by the Undergraduate Research Opportunity 
Program grant and the Department of Veterans Affairs, Veterans Health Administration, Health 
Services Research & Development Service (IAC 05-254-3; Illness Management and Recovery 
for Veterans with Severe Mental Illness).  The views expressed in this paper are those of the 
authors and do not necessarily represent those of the Department of Veterans Affairs. 
 
 
References 
Alegria, M., Polo, A., Gao, S., Santana, L., Rothstein, D., Jimenez, A., Lyons Hunter, M., 
Mendieta, F., Oddo, V., Normand, S. L., 2008. Evaluation of a patient activation and 
empowerment intervention in mental health care. Medical Care 46,247-256. 
Alegria M., Sribney W., Perez D., Laderman K., Keefe K., 2009. The Role of Patient 
Activation on Patient–Provider Communication and Quality of Care for US and 
Foreign Born Latino Patients. Journal of General Internal Medicine 24, 534-541. 
Alexander, J. A., Hearld, L.R., Mittler, J. N., Harvey, J., 2012. Patient-physician role 
relationships and patient activation among individuals with chronic illnesses. Health 
Services Research 47, 1201-122.   
Bollen, K.A., 1989. Structural equations with latent variables. Wiley, New York. 
Callahan, C. M., Unverzagt, F. W., L., H. S., Perkins, A. J.,  Hendrie, H. C., 2002. A six-item 
screener to identify cognitive impairment among potential subjects for clinical research. 
Medical Care 40, 771-781. 
Cheavens, J., Feldman, D., Gum, A., Michael, S., Snyder, C., 2006. Hope therapy in a 
community sample: a pilot investigation. Social Indicators Research 77, 61-78. 
Corrigan, P.W., Salzer, K., Ralph, R.O., Sangster, Y., Keck, L., (2004). Examining the factor 
structure of the Recovery Assessment Scale. Schizophrenia Bulletin 30, 1035-1041. 
Dickerson, R. J., 2002. Hope and self-esteem as outcome measures of a psychiatric inpatient 
cognitive-behavioral treatment program. Dissertation Abstracts International: Section B. 
Sciences and Engineering, 63 (6-B), 3004. 
Deegan, P. E., 1988. Recovery: The lived experience of rehabilitation. Psychosocial 
Rehabilitation Journal 11, 11-19. 
Running head: PATIENT ACTIVATION AND HOPE IN SCHIZOPHRENIA 
16 
 
Deegan, Patricia E. "There's a Person In Here." The Sixth Annual Mental Health Services 
Conference of Australia and New Zealand. Brisbane, Australia. 16 Sept. 1996. 
Druss, B. G., Zhao, L., Esenwein S. A., Bona J. R., Fricks, L.,  Jenkins-Tucker, S., Sterling, E., 
DiClemente, R.,  Lorig, K., 2010. The heath and recovery peer (HARP) program: A peer-
led intervention to improve medical self-management for persons with serious mental 
illness. Schizophrenia Research 118, 264-270. 
First, M. B., Spitzer, R. L., Gibbon, M., & Williams, J. B. W., 1996. Structured Clinical 
Interview for DSM-IV Axis-I Disorders - Patient Edition (SCID-I/P, Version 2.0). 
Biometrics Research Department, New York. 
Green, C. A., Perrin, N. A., Polen, M. R., Leo, M. C., Hibbard, J. H., Tusler M., 2010. 
Development of the Patient Activation Measure for mental health. Administration and 
Policy in Mental Health and Mental Health Services Research 37, 327-333. 
Hibbard, J. H., Stockard, J., Mahoney, E. R., Tusler, M., 2004. Development of the Patient 
Activation Measure (PAM): Conceptualizing and measuring activation in patients and 
consumers. Health Services Research 39, 1005-1026. 
Hibbard, J. H., Mahoney, E. R., Stockard, J., Tusler, M., 2005. Development and testing of a 
short form of the Patient Activation Measure. Health Services Research 40, 1918-1930. 
Hibbard, J. H., Mahoney, E. R., Stock, R., Tusler, M., 2007. Self-management and health care 
utilization: Do increases in patient activation result in improved self-management 
behaviors? Health Services Research 42, 1443-1463. 
Hoffmann, H., Kupper, Z., Kunz, B., 2000. Hopelessness and its impact on rehabilitation 
outcome in schizophrenia-an exploratory study. Schizophrenia Research 43, 147-158. 
Running head: PATIENT ACTIVATION AND HOPE IN SCHIZOPHRENIA 
17 
 
Hu, L., Bentler, P.M. (1999). Cutoff criteria for fit indexes in covariance structure analysis: 
Conventional criteria versus new alternatives. Structural  Equation Modeling 6, 1-55. 
Irving, L. M., Snyder C. R., Cheavens, J., Gravel, L., Hilberg, P., Nelson, N, 2004. The 
relationships between hope and outcomes in the pretreatment, beginning, and later phases 
of psychotherapy. Journal of Psychotherapy Integrations 14, 419-443. 
Kirkpatrick, H., Landeen, J., Woodside, H., Byrne, C., 2001. How people with schizophrenia 
build their hope. Journal of Psychosocial Nursing and Mental Health Services 39, 46-53. 
Kukla, M., Salyers, M., Lysaker, P. H., 2013. Levels of patient activation among adults with 
schizophrenia. Journal of Nervous and Mental Disease 201, 339-344. 
Little, T. D., Preacher, K. J., Selig, J. P., Card, N. A., 2007. New developments in SEM panel 
analyses of longitudinal data. International Journal of Behavioral Development 31, 357-
365. 
Little, T. D., 2013. Longitudinal Structural Equation Modeling. Guilford Press, New York.  
Lysaker, P. H., Salyers M. P., Tsai J., Yorkman Spurrier L., Davis L.V., 2008. Clinical and 
psychological correlates of two domains of hopelessness in schizophrenia. Journal of 
Rehabilitation Research and Development 45, 911-920. 
Maindal, H. T., Sokolowski I.,  Vedsted, P., 2009. Translation, adaptation and validation of the 
American short form Patient Activation Measure (PAM13) in a Danish version. BMC 
Public Health 9, 209-207. 
McCann T. V., 2002. Uncovering hope with clients who have psychotic illness. Journal of 
Holistic Nursing 20, 81–99. 
Running head: PATIENT ACTIVATION AND HOPE IN SCHIZOPHRENIA 
18 
 
McGrew, J. H., Johannesen, J. K., Griss, M. E., Born, D., Vogler, T., 2004. Results-based 
Funding in Indiana: Process, Outcomes and Caveats. Paper presented at the National 
Conference of the Association of Persons in Supported Employment, Indianapolis, IN. 
Mosen, D. M, Schmittdiel J., Hibbard, J., Sobel, D., Remmers C., Bellows, J., 2006. Is Patient 
Activation associated with outcomes of care for adults with chronic conditions? Journal 
of Ambulatory Care Management 30, 21–29. 
Mueser, K. T., Gingerich, S., 2005. Illness Management and Recovery (IMR) Scales, in:  
Campbell-Orde, T.,  Chamberlin, J., Carpenter, J.,  Leff, H.S. (Eds.), Measuring the 
Promise: A Compendium of Recovery Measures, Evaluation Center @ Human Services 
Research Institute, Cambridge., pp. 124-132. 
Muthén, L. K., Muthén, B. O., 1998-2013. Mplus user’s guide, sixth ed. Muthén & Muthén, Los 
Angeles.   
President's New Freedom Commission on Mental Health. Achieving the promise: transforming 
mental health care in America. Final report. DHHS Pub. No. SMA-03-3832. 2003. 
Rockville, MD, Substance Abuse and Mental Health Services Administration. 
Rademakers J., Nijman J., Hoek L., Heijmans M., Rijken M., 2012.  Measuring patient activation 
in the Netherlands: translation and validation of the American short form Patient 
Activation Measure (PAM13). BMC Public Health 12, 577.   
Salyers, M. P., Matthias, M. S., Spann, C. L., Lydick, J. M., Rollins, A. L., Frankel, R. M., 2009. 
The role of patient activation in psychiatric visits. Psychiatric Services 60, 1535-1539. 
Salyers, M. P., McGuire, A. B., Kukla, M., Fukui, S., Lysaker, P.H., Mueser, K. T., 2014. A 
randomized controlled trial of Illness Management and Recovery with an active control 
condition. Psychiatric Services 65, 1005-1111.  
Running head: PATIENT ACTIVATION AND HOPE IN SCHIZOPHRENIA 
19 
 
Schrank, B., Bird, V., Rudnick, A., Slade, M., 2012. Determinants, self-management strategies 
and interventions for hope in people with mental disorders: Systematic search and 
narrative review. Social Science and Medicine 74, 554-564. 
Skolasky, R. L., Mackenzie, E. J., Riley, L. H., Wegener, S. T., 2009. Psychometric properties of 
the patient activation measure among individuals presenting for elective lumbar spine 
surgery. Quality of Life Research 18, 1357-1366. 
Snyder, C. R., 1994. The psychology of hope: You can get there from here. Free Press, New 
York. 
Snyder, C. R., Sympson, S. C., Ybasco, F. C., Borders, T. F., Babyak, M. A., Higgins, R. L. 
1996. Development and validation of the State Hope Scale. Journal of Personality and 
Social Psychology 70, 321-335. 
Snyder, C. R., LaPointe, A. B., Crowson, Jr.  J. J., Early S., 1998. Preferences of High- and Low-
hope People for Self-referential Input. Cognition and Emotion 12, 807-823. 
Tollett, J. H., Thomas, S. P., 1995. A theory-based nursing intervention to instill hope in 
homeless veterans. Advances in Nursing Science 18, 76-90. 
Weis, R., Speridakos, E. C., 2011. A Meta-Analysis of hope enhancement strategies in clinical 
and community settings. Psychology of Well-Being: Theory, Research and Practice, 1:5.  
Wu, W., Selig, J. N., Little, T. D., 2013. Longitudinal data analysis. In Little, T.D. (Eds.) 
Handbook of Quantitative Methods. Oxford. 
 
 
 
Running head: PATIENT ACTIVATION AND HOPE IN SCHIZOPHRENIA 
20 
 
Fig. 1. 
Cross-lagged panel model (the final model). 
 
βs can be interpreted as standardized regression coefficients. β1 and β2 are autoregressive 
coefficients equated across time, showing the effect of a previous measure on a subsequent 
measure of the same variable. β3 and β4 are cross-lagged regression coefficients, showing the 
effect of a previous measure on the subsequent measure of the different variable.  β3 shows the 
effects of hope on subsequent patient activation, while β4 shows effects of patient activation on 
subsequent hope. The finding that β3 and β4 were not significantly different from each other 
indicates mutual influences. ф/Ѱs are standardized covariances and can be interpreted as 
correlations. The failure to reject the null hypothesis in χ² indicates that the observed model and 
the hypothesized model are not significantly different (i.e., the model fits the data). The upper 
limit of the CI for RMSEA was less than .05 indicating a good fit (the value is approximately 
zero because the model is close to being saturated). Both CFI and TLI are comparative fit 
indices, with a value of 1.0 indicating a good fit. SRMR is an absolute fit index, with closer to 
zero implying a good fit. 
 
 
 
 
 
Patient 
Activation β1=.37 β1 =.37
β2 =.50 β2 =.50
β3 =.22 β3 =.22
β4 =.16 β4 =.16
Ψ1 =.32φ1 =.55 Ψ1 =.32
Baseline 9 months 18 months
HOPE HOPE HOPE
χ2(9, n=118)=4.224, p=.90, Root Mean Square Error of Approximation =0.0 (90%CL=0 ‐ 0.046), Comparative Fit Index =1.00, Tucker‐Lewis Index =1.00, Standardized Root Mean 
Square Residual =0.032
Patient 
Activation
Patient 
Activation
Running head: PATIENT ACTIVATION AND HOPE IN SCHIZOPHRENIA 
21 
 
 
Table 1. 
Correlations among hope, patient activation and background variables.  
 
     1    2    3     4      5     6     7     8     9    10
1. Gender 
(Female) 
    1           
2. Age -.01     1          
3. Race (White) -.14 -.16     1         
4. Education 
(Beyond 
College) 
-.07  .10   .29 **     1        
5. Hope BL  .10  .03 -.14 -.12      1      
6. Patient 
Activation BL 
-.03 -.04  .01  .02   .57 **     1     
7. Hope 9 mo  .02  .12 -.09 -.07   .61 **  .46 **     1    
8. Patient 
Activation 9 
mo 
-.09  .01 -.13 -.08   .43 **  .51 **  .62 **     1   
9. Hope 18 mo -.06 -.13 -.17 -.07   .47 **  .36 **  .59 **  .49 **     1  
10. Patient 
Activation 18 
mo 
-.06 -.02 -.16  .03   .33 **  .34 **  .50 **  .53 **  .67 **     1
Note  **p < .01 
 
 
